The SNIS Annual Meeting is recognized as one of the most respected conferences in neurointerventional surgery, attracting experts focused on stroke intervention, neurovascular disorders, advanced imaging, and minimally invasive treatment procedures. Attendees gain access to scientific sessions, research presentations, educational workshops, and networking opportunities designed to improve clinical outcomes.
The contact database provides valuable access to healthcare professionals, researchers, fellows, and medical technology providers seeking new innovations and collaborative opportunities within neurovascular medicine.
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
The SNIS 23rd Annual Meeting & Fellows Course 2026 is recognized as one of the most influential conferences in neurointerventional surgery, providing a valuable platform for physicians, surgeons, neurologists, radiologists, fellows, researchers, healthcare executives, and industry innovators. The event focuses on advancing neurovascular care through scientific education, clinical collaboration, and technology-driven healthcare solutions.
Attendees can explore the latest developments in stroke treatment, brain hemorrhage management, vascular disorders, neuroimaging technologies, minimally invasive interventions, and patient outcome optimization. Through scientific sessions, research presentations, expert discussions, professional networking, and industry exhibitions, participants gain insights into the future of neurointerventional medicine and clinical innovation.
SNIS 2026 brings together leading medical device manufacturers, pharmaceutical companies, imaging technology providers, healthcare innovators, research organizations, and neurovascular solution providers supporting advancements in neurointerventional surgery and patient care.
Organizations advancing patient care through innovative treatment technologies and clinical expertise.
Companies presenting minimally invasive devices designed for neurovascular procedures.
Exhibitors showcasing advanced imaging equipment and visualization technologies.
Industry participants supporting research, development, and innovation across healthcare sectors.
Organizations focused on education, certification, and professional skill development.
Companies introducing next-generation products and solutions for modern healthcare environments.
Experts focused on improving treatment pathways and patient outcomes in stroke care.
Clinicians performing advanced neurovascular and endovascular procedures.
Professionals advancing education, research, and evidence-based clinical practices.
Decision-makers responsible for operational excellence and technology adoption.
Professionals assessing equipment, procedural tools, and treatment technologies.
Specialists exploring digital platforms, imaging tools, and clinical workflow solutions.
Built for medical device manufacturers, pharmaceutical companies, imaging technology providers, healthcare organizations, research institutions, and clinical service providers, the SNIS 2026 contact database delivers comprehensive attendee and exhibitor information from one of the leading neurointerventional surgery conferences worldwide.
These data fields help medical device manufacturers, pharmaceutical companies, healthcare technology providers, research institutions, and healthcare organizations build targeted outreach campaigns and connect with qualified professionals attending SNIS 2026.
Connect with neurointerventional surgeons, neurologists, radiologists, and stroke care experts.
Identify professionals evaluating medical devices, imaging systems, pharmaceuticals, and clinical solutions.
Engage healthcare leaders actively exploring emerging technologies and treatment advancements.
Target ideal prospects using advanced filters based on specialty, geography, organization type, and seniority.
Increase awareness among healthcare professionals seeking innovative products and services.
Build valuable relationships that support clinical collaboration, business growth, and market expansion.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
Gain access to a representative sample of the SNIS 23rd Annual Meeting & Fellows Course 2026 attendee and exhibitor database. Explore records featuring neurointerventional surgeons, neurologists, radiologists, stroke specialists, fellows, researchers, healthcare executives, medical device professionals, pharmaceutical representatives, and healthcare innovators actively involved in neurovascular care and clinical advancement.
Designed for medical device manufacturers, pharmaceutical companies, imaging technology providers, healthcare service organizations, research institutions, and clinical solution providers, the sample demonstrates how targeted contact data can support physician outreach, lead generation, product promotion, partnership development, and healthcare marketing initiatives.
Access specialists dedicated to improving stroke diagnosis, intervention, and patient outcomes.
Identify healthcare organizations evaluating equipment, procedural technologies, and clinical tools.
Connect with educators, researchers, fellows, and scientific contributors within neurovascular medicine.
Reach highly relevant healthcare audiences through customized segmentation and outreach strategies.
Increase visibility among physicians, healthcare leaders, and clinical decision-makers.
Develop meaningful relationships that contribute to sustainable growth and healthcare market success.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
Medical device manufacturers, pharmaceutical companies, healthcare technology providers, research institutions, healthcare consulting firms, and clinical service organizations can benefit from the database.
Yes. You can target professionals based on neurointerventional surgery, stroke care, radiology, neurology, vascular medicine, and clinical research.
Yes. Available records may include hospital names, healthcare organizations, websites, department information, and professional contact details.
Yes. Prospects can be filtered by country, state, region, city, or specific service areas.
Yes. Sample records are available to help evaluate database quality, structure, and audience relevance.
Yes. Audience segments can be tailored for neurointerventional surgeons, neurologists, radiologists, stroke specialists, fellows, researchers, and healthcare executives.
Organizations use it for community outreach, awareness campaigns, partnership development, event promotion, and program expansion.